[English] 日本語

- EMDB-53222: Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc (15 mol% DOPS, 5 mol% Cholesterol) | |||||||||
![]() | human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5 mol% Cholesterol), map M5 (consensus map) | |||||||||
![]() |
| |||||||||
![]() | Ferlins / myoferlin / multi-C2 domains / lipid nanodisc / MEMBRANE PROTEIN | |||||||||
Function / homology | ![]() regulation of neurotransmitter secretion / plasma membrane repair / blood circulation / muscle contraction / caveola / phospholipid binding / centriolar satellite / synaptic vesicle membrane / nuclear envelope / cytoplasmic vesicle ...regulation of neurotransmitter secretion / plasma membrane repair / blood circulation / muscle contraction / caveola / phospholipid binding / centriolar satellite / synaptic vesicle membrane / nuclear envelope / cytoplasmic vesicle / nuclear membrane / ciliary basal body / cilium / intracellular membrane-bounded organelle / calcium ion binding / extracellular exosome / plasma membrane Similarity search - Function | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 2.74 Å | |||||||||
![]() | Cretu C / Moser T | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Structural insights into lipid membrane binding by human ferlins. Authors: Constantin Cretu / Aleksandar Chernev / Csaba Zoltán Kibédi Szabó / Vladimir Pena / Henning Urlaub / Tobias Moser / Julia Preobraschenski / ![]() ![]() Abstract: Ferlins are ancient membrane proteins with a unique architecture, and play central roles in crucial processes that involve Ca-dependent vesicle fusion. Despite their links to multiple human diseases ...Ferlins are ancient membrane proteins with a unique architecture, and play central roles in crucial processes that involve Ca-dependent vesicle fusion. Despite their links to multiple human diseases and numerous functional studies, a mechanistic understanding of how these multi-C domain-containing proteins interact with lipid membranes to promote membrane remodelling and fusion is currently lacking. Here we obtain near-complete cryo-electron microscopy structures of human myoferlin and dysferlin in their Ca- and lipid-bound states. We show that ferlins adopt compact, ring-like tertiary structures upon membrane binding. The top arch of the ferlin ring, composed of the CC-CD region, is rigid and exhibits only little variability across the observed functional states. In contrast, the N-terminal CB and the C-terminal CF-CG domains cycle between alternative conformations and, in response to Ca, close the ferlin ring, promoting tight interaction with the target membrane. Probing key domain interfaces validates the observed architecture, and informs a model of how ferlins engage lipid bilayers in a Ca-dependent manner. This work reveals the general principles of human ferlin structures and provides a framework for future analyses of ferlin-dependent cellular functions and disease mechanisms. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 88.9 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 25.7 KB 25.7 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 11.9 KB | Display | ![]() |
Images | ![]() | 56 KB | ||
Masks | ![]() | 178 MB | ![]() | |
Filedesc metadata | ![]() | 8.3 KB | ||
Others | ![]() ![]() ![]() | 88.7 MB 165.3 MB 165.3 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 962.7 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 962.3 KB | Display | |
Data in XML | ![]() | 20.8 KB | Display | |
Data in CIF | ![]() | 26.8 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9qkvMC ![]() 9h6xC ![]() 9qleC ![]() 9qlfC ![]() 9qlnC ![]() 9qlsC C: citing same article ( M: atomic model generated by this map |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5 mol% Cholesterol), map M5 (consensus map) | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.72 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5...
File | emd_53222_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5 mol% Cholesterol), overall map (map M6) | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5...
File | emd_53222_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5 mol% Cholesterol), half map A (map M5, consensus map) | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5...
File | emd_53222_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | human myoferlin (1-1997)-MSP2N2 complex (15 mol% DOPS, 5 mol% Cholesterol), half map B (map M5, consensus map) | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc...
Entire | Name: Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc (comprising 15 mol% DOPS, 5 mol% Cholesterol) |
---|---|
Components |
|
-Supramolecule #1: Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc...
Supramolecule | Name: Human myoferlin (1-1997) in complex with an MSP2N2 lipid nanodisc (comprising 15 mol% DOPS, 5 mol% Cholesterol) type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: ![]() |
-Macromolecule #1: Myoferlin
Macromolecule | Name: Myoferlin / type: protein_or_peptide / ID: 1 Details: The cytosolic domain of human myoferlin (residues 1-1997), cloned in-frame with a twin-StrepII affinity tag. Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 232.625953 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: MASWSHPQFE KGGGSGGGSG GGSWSHPQFE KLEVLFQGPG SGDKDCEQSN AMLRVIVESA SNIPKTKFGK PDPIVSVIFK DEKKKTKKV DNELNPVWNE ILEFDLRGIP LDFSSSLGII VKDFETIGQN KLIGTATVAL KDLTGDQSRS LPYKLISLLN E RGQDTGAT ...String: MASWSHPQFE KGGGSGGGSG GGSWSHPQFE KLEVLFQGPG SGDKDCEQSN AMLRVIVESA SNIPKTKFGK PDPIVSVIFK DEKKKTKKV DNELNPVWNE ILEFDLRGIP LDFSSSLGII VKDFETIGQN KLIGTATVAL KDLTGDQSRS LPYKLISLLN E RGQDTGAT IDLVIGYDPP SAPHPNDLSG PSVPGMGGDG EEDEGDEDRL DNAVRGPGPK GPVGTVSEAQ LARRLTKVKN SR RMLSNKP QDFQIRVRVI EGRQLSGNNI RPVVKVHVCG QTHRTRIKRG NNPFFDELFF YNVNMTPSEL MDEIISIRVY NSH SLRADC LMGEFKIDVG FVYDEPGHAV MRKWLLLNDP EDTSSGSKGY MKVSMFVLGT GDEPPPERRD RDNDSDDVES NLLL PAGIA LRWVTFLLKI YRAEDIPQMD DAFSQTVKEI FGGNADKKNL VDPFVEVSFA GKKVCTNIIE KNANPEWNQV VNLQI KFPS VCEKIKLTIY DWDRLTKNDV VGTTYLHLSK IAASGGEVED FSSSGTGAAS YTVNTGETEV GFVPTFGPCY LNLYGS PRE YTGFPDPYDE LNTGKGEGVA YRGRILVELA TFLEKTPPDK KLEPISNDDL LVVEKYQRRR KYSLSAVFHS ATMLQDV GE AIQFEVSIGN YGNRFDTTCK PLASTTQYSR AVFDGNYYYY LPWAHTKPVV TLTSYWEDIS HRLDAVNTLL AMAERLQT N IEALKSGIQG KIPANQLAEL WLKLIDEVIE DTRYTLPLTE GKANVTVLDT QIRKLRSRSL SQIHEAAVRM RSEATDVKS TLAEIEDWLD KLMQLTEEPQ NSMPDIIIWM IRGEKRLAYA RIPAHQVLYS TSGENASGKY CGKTQTIFLK YPQEKNNGPK VPVELRVNI WLGLSAVEKK FNSFAEGTFT VFAEMYENQA LMFGKWGTSG LVGRHKFSDV TGKIKLKREF FLPPKGWEWE G EWIVDPER SLLTEADAGH TEFTDEVYQN ESRYPGGDWK PAEDTYTDAN GDKAASPSEL TCPPGWEWED DAWSYDINRA VD EKGWEYG ITIPPDHKPK SWVAAEKMYH THRRRRLVRK RKKDLTQTAS STARAMEELQ DQEGWEYASL IGWKFHWKQR SSD TFRRRR WRRKMAPSET HGAAAIFKLE GALGADTTED GDEKSLEKQK HSATTVFGAN TPIVSCNFDR VYIYHLRCYV YQAR NLLAL DKDSFSDPYA HICFLHRSKT TEIIHSTLNP TWDQTIIFDE VEIYGEPQTV LQNPPKVIME LFDNDQVGKD EFLGR SIFS PVVKLNSEMD ITPKLLWHPV MNGDKACGDV LVTAELILRG KDGSNLPILP PQRAPNLYMV PQGIRPVVQL TAIEIL AWG LRNMKNFQMA SITSPSLVVE CGGERVESVV IKNLKKTPNF PSSVLFMKVF LPKEELYMPP LVIKVIDHRQ FGRKPVV GQ CTIERLDRFR CDPYAGKEDI VPQLKASLLS APPCRDIVIE MEDTKPLLAS KLTEKEEEIV DWWSKFYASS GEHEKCGQ Y IQKGYSKLKI YNCELENVAE FEGLTDFSDT FKLYRGKSDE NEDPSVVGEF KGSFRIYPLP DDPSVPAPPR QFRELPDSV PQECTVRIYI VRGLELQPQD NNGLCDPYIK ITLGKKVIED RDHYIPNTLN PVFGRMYELS CYLPQEKDLK ISVYDYDTFT RDEKVGETI IDLENRFLSR FGSHCGIPEE YCVSGVNTWR DQLRPTQLLQ NVARFKGFPQ PILSEDGSRI RYGGRDYSLD E FEANKILH QHLGAPEERL ALHILRTQGL VPEHVETRTL HSTFQPNISQ GKLQMWVDVF PKSLGPPGPP FNITPRKAKK YY LRVIIWN TKDVILDEKS ITGEEMSDIY VKGWVPGNEE NKQKTDVHYR SLDGEGNFNW RFVFPFDYLP AEQLCIVAKK EHF WSIDQT EFRIPPRLII QIWDNDKFSL DDYLGFLELD LRHTIIPAKS PEKCRLDMIP DLKAMNPLKA KTASLFEQKS MKGW WPCYA EKDGARVMAG KVEMTLEILN EKEADERPAG KGRDEPNMNP KLD UniProtKB: Myoferlin |
-Macromolecule #2: 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE
Macromolecule | Name: 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE / type: ligand / ID: 2 / Number of copies: 2 / Formula: PSF |
---|---|
Molecular weight | Theoretical: 455.437 Da |
Chemical component information | ![]() ChemComp-PSF: |
-Macromolecule #3: CALCIUM ION
Macromolecule | Name: CALCIUM ION / type: ligand / ID: 3 / Number of copies: 10 / Formula: CA |
---|---|
Molecular weight | Theoretical: 40.078 Da |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 0.77 mg/mL | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
| ||||||||||||||||||
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 200 / Support film - Material: CARBON / Support film - topology: HOLEY / Pretreatment - Type: PLASMA CLEANING / Pretreatment - Time: 60 sec. / Pretreatment - Atmosphere: AIR Details: The grid was treated with the Plasma Cleaner (Harrick Plasma) for 1 min at medium settings, followed by vitrification in liquid ethane-propane (37%/63%), cooled by liquid nitrogen | ||||||||||||||||||
Vitrification | Cryogen name: ETHANE-PROPANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV | ||||||||||||||||||
Details | Prior to cryo-EM grid preparation, the sample was crosslinked with glutaraldehyde (0.05 % (v/v)) in batch and purified by size-exclusion chromatography |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Specialist optics | Energy filter - Name: TFS Selectris / Energy filter - Slit width: 10 eV |
Software | Name: EPU (ver. v.3.6) |
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Number grids imaged: 1 / Number real images: 9800 / Average exposure time: 3.45 sec. / Average electron dose: 39.85 e/Å2 / Details: 9621 movies were accepted after curation |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 165000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | Chain - Source name: AlphaFold / Chain - Initial model type: in silico model |
---|---|
Refinement | Space: REAL / Protocol: AB INITIO MODEL / Overall B value: 135.43 |
Output model | ![]() PDB-9qkv: |